Responses
Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
1252 Immune checkpoint inhibitor-induced diabetes mellitus comprises multiple clinical endotypes with distinct immunologic features
Compose a Response to This Article
Other responses
No responses have been published for this article.
